AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seppo, L.
Right arrow Articles by Korpela, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seppo, L.
Right arrow Articles by Korpela, R.
Agricola
Right arrow Articles by Seppo, L.
Right arrow Articles by Korpela, R.
American Journal of Clinical Nutrition, Vol. 77, No. 2, 326-330, February 2003
© 2003 American Society for Clinical Nutrition


Original Research Communication

A fermented milk high in bioactive peptides has a blood pressure–lowering effect in hypertensive subjects1,2,3

Leena Seppo, Tiina Jauhiainen, Tuija Poussa and Riitta Korpela

1 From the Valio, Ltd, Research Center, Helsinki (LS, TJ, and RK); Stat-Consulting, Tampere, Finland (TP); the Foundation for Nutrition Research, Helsinki (RK); and the Institute of Biomedicine, University of Helsinki (TJ and RK).

Background: Angiotensin-converting enzyme (ACE; EC 3.4.15.1) plays a dual role in the regulation of hypertension: it catalyzes the production of the vasoconstrictor angiotensin II and it inactivates the vasodilator bradykinin. By inhibiting these processes, ACE inhibitors have antihypertensive effects. Peptides derived from milk proteins can have ACE-inhibiting properties and may thus be used as antihypertensive components.

Objective: We evaluated the long-term blood pressure–lowering effect of milk fermented by Lactobacillus helveticus LBK-16H in hypertensive subjects.

Design: In a randomized placebo-controlled study, 39 hypertensive patients received 150 mL/d of either L. helveticus LBK-16H fermented milk or a control product for 21 wk after a 2-wk run-in period. During the run-in period, the average baseline diastolic and systolic blood pressure values were 155 and 97 mm Hg, respectively, in the test product group and 152 and 96 mm Hg, respectively, in the control group. After the run-in period, blood pressure was measured at home on the same day every week with the use of an automatic blood pressure recorder.

Results: There was a mean difference of 6.7 ± 3.0 mm Hg in systolic blood pressure (P = 0.030) and of 3.6 ± 1.9 mm Hg (P = 0.059) in diastolic blood pressure between the test product and control groups. Demographic factors had no significant effect on the responses.

Conclusion: L. helveticus LBK-16H fermented milk containing bioactive peptides in normal daily use has a blood pressure–lowering effect in hypertensive subjects.

Key Words: Fermented milk • bioactive peptides • blood pressure • Lactobacillus helveticus • hypertension • valine-proline-proline • isoleusine-proline-proline • angiotensin-converting enzyme inhibitors




This article has been cited by other articles:


Home page
HypertensionHome page
M. F. Engberink, E. G. Schouten, F. J. Kok, L. A.J. van Mierlo, I. A. Brouwer, and J. M. Geleijnse
Lactotripeptides Show No Effect on Human Blood Pressure: Results From a Double-Blind Randomized Controlled Trial
Hypertension, February 1, 2008; 51(2): 399 - 405.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
U. Butikofer, J. Meyer, R. Sieber, B. Walther, and D. Wechsler
Occurrence of the Angiotensin-Converting Enzyme Inhibiting Tripeptides Val-Pro-Pro and Ile-Pro-Pro in Different Cheese Varieties of Swiss Origin
J Dairy Sci, January 1, 2008; 91(1): 29 - 38.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. S. Heimann, I. Gomes, C. S. Dale, R. L. Pagano, A. Gupta, L. L. de Souza, A. D. Luchessi, L. M. Castro, R. Giorgi, V. Rioli, et al.
Hemopressin is an inverse agonist of CB1 cannabinoid receptors
PNAS, December 18, 2007; 104(51): 20588 - 20593.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Foltz, E. E. Meynen, V. Bianco, C. van Platerink, T. M. M. G. Koning, and J. Kloek
Angiotensin Converting Enzyme Inhibitory Peptides from a Lactotripeptide-Enriched Milk Beverage Are Absorbed Intact into the Circulation
J. Nutr., April 1, 2007; 137(4): 953 - 958.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
T. Jauhiainen and R. Korpela
Milk Peptides and Blood Pressure
J. Nutr., March 1, 2007; 137(3): 825S - 829S.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
A. Quiros, M. Ramos, B. Muguerza, M. A. Delgado, P. J. Martin-Alvarez, A. Aleixandre, and I. Recio
Determination of the Antihypertensive Peptide LHLPLP in Fermented Milk by High-Performance Liquid Chromatography-Mass Spectrometry
J Dairy Sci, December 1, 2006; 89(12): 4527 - 4535.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
G. Scolari, M. Vescovo, C. Zacconi, and F. Vescovi
Extraction and Partial Characterization of Proteolytic Activities from the Cell Surface of Lactobacillus helveticus Zuc2.
J Dairy Sci, October 1, 2006; 89(10): 3800 - 3809.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
A. Geerlings, I. C. Villar, F. H. Zarco, M. Sanchez, R. Vera, A. Z. Gomez, J. Boza, and J. Duarte
Identification and characterization of novel Angiotensin-converting enzyme inhibitors obtained from goat milk.
J Dairy Sci, September 1, 2006; 89(9): 3326 - 3335.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
M. Miguel, I. Recio, M. Ramos, M. A. Delgado, and M. A. Aleixandre
Antihypertensive Effect of Peptides Obtained from Enterococcus faecalis-Fermented Milk in Rats.
J Dairy Sci, September 1, 2006; 89(9): 3352 - 3359.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
K. Aihara, O. Kajimoto, H. Hirata, R. Takahashi, and Y. Nakamura
Effect of Powdered Fermented Milk with Lactobacillus helveticus on Subjects with High-Normal Blood Pressure or Mild Hypertension
J. Am. Coll. Nutr., August 1, 2005; 24(4): 257 - 265.
[Abstract] [Full Text] [PDF]


Home page
AAP Grand RoundsHome page
D. R. Neuspiel
Dietary Fruit, Vegetable, and Dairy Intake Leads to Lasting Blood Pressure Changes
AAP Grand Rounds, May 1, 2005; 13(5): 58 - 58.
[Full Text] [PDF]


Home page
J DAIRY SCIHome page
D. J. Walsh, H. Bernard, B. A. Murray, J. MacDonald, A.-K. Pentzien, G. A. Wright, J.-M. Wal, A. D. Struthers, H. Meisel, and R. J. FitzGerald
In Vitro Generation and Stability of the Lactokinin {beta}-Lactoglobulin Fragment (142-148)
J Dairy Sci, November 1, 2004; 87(11): 3845 - 3857.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
T. Psaltopoulou, A. Naska, P. Orfanos, D. Trichopoulos, T. Mountokalakis, and A. Trichopoulou
Olive oil, the Mediterranean diet, and arterial blood pressure: the Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study
Am. J. Clinical Nutrition, October 1, 2004; 80(4): 1012 - 1018.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
M. Murakami, H. Tonouchi, R. Takahashi, H. Kitazawa, Y. Kawai, H. Negishi, and T. Saito
Structural Analysis of a New Anti-Hypertensive Peptide ({beta}-Lactosin B) Isolated from a Commercial Whey Product
J Dairy Sci, July 1, 2004; 87(7): 1967 - 1974.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. J. FitzGerald, B. A. Murray, and D. J. Walsh
Hypotensive Peptides from Milk Proteins
J. Nutr., April 1, 2004; 134(4): 980S - 988S.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by The American Society for Nutrition